Immuneering Corp (IMRX) stock
IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.71+0.04 (+1.09%)
Close on Nov 13, 2026Market cap $240.27MP/E –Yield –
Immuneering price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Immuneering's price to sales ratio was 407.1× on Feb 28, 2023, against 48.9× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 407.1× | +154.9 |
| 2022 | Dec 30, 2022 | 252.2× | +199.7 |
| 2021 | Dec 31, 2021 | 52.4× | – |
See a number that looks wrong?